DNA technology provides novel strategy for delivery of complex anti-HIV agent

Scientists at The Wistar Institute have applied their synthetic DNA technology to engineer a novel eCD4-Ig anti-HIV agent and to enhance its potency in vivo, providing a new simple strategy for constructing complex therapeutics for infectious agents as well as for diverse implications in therapeutic delivery.

Top News

Ain't No God; don't even think about theism

UnFox News: not a propaganda arm of the Republican party